OSTEOPOROSIS IS A PROBLEM OF THE ELDERLY: TO ACCEPT OR TO BE TREATED?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper gives data on optimizing the diagnosis and treatment of osteoporosis in the elderly. X-ray absorption was used to measure bone mineral density and cavitary mass sizes before and after therapy. Comparison of 3 medications could determine the most effective drug for the treatment of osteoporosis in elderly patients with androgen deficiency.

Full Text

Restricted Access

About the authors

V. Strukov

Penza Institute for Postgraduate Training of Physicians

V. Potapov

Russian Medical Academy of Postgraduate Education

A. Kislov

Penza Institute for Postgraduate Training of Physicians

I. Boikov

Penza State University

D. Elistratov

OOO «Parafarm»

M. Bazhenov

Regional Children’s Clinical Hospital

Penza

Yu. Semerich

Penza State University

L. Burmistrova

Research Institute of Apiculture

Rybnoe

N. Eremina

Penza Institute for Postgraduate Training of Physicians

M. Maksimova

Penza Institute for Postgraduate Training of Physicians

References

  1. Durie B., Katz M. Croweiy J. Osteonecrosis of the jaw and bifosfonates // N. Engl. J. Med. - 2005; 21: 99-102.
  2. Murad O., Arora S., Farag A. et al. Bisphosphonates and osteonecrosis of the jaw: a retrospective study // Endocr. Pract. - 2007; 13 (3): 232-8.
  3. Montebugnoli L., Felicetti L., Gissi D. et al. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. - 2007; 104 (4): 473-7.
  4. Gunther C. et al. Beneficial Effect of PTH on Spine BMD and Microarchitecture (TBS) Parameters in Postmenopausal Women with Osteoporosis. A 2-Year Study. Osteoporosis Int. - 2012; 23 (2): 85-386.
  5. Hans D. et al. Beneficial Effects of Strontium Ranelate Compared to Alendronate on TBS Menopausal Osteoporotic Women. A 2-Year Study. Osteoporosis Int. 2012 23 (2): 85-386.
  6. Leslie W., Kanis J. Lumbar spine TBS is a FRAX independent risk factor for fracture. The Manitoba BMD Cohort. ISCD Annual meeting 2013. Tampa, Florida.
  7. Бойков И.В., Струков В.И., Семерич Ю.С. Программа определения степени поражения пациента остеопорозом. Свидетельство о государственной регистрации программы для ЭВМ № 2013660284 от 10.09.2013.
  8. Bruyere O. et al. Strontion Ranelateon spinal osteoarthritis progression // Ann. Rheumatol. Dis. - 2008; 67: 335-9.
  9. Kalinchenko S., Vishnevskiy E., Koval A. et al. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study // The Aging Male. - 2008; 11 (2): 57-61.
  10. Струков В.И., Джоунс О.В., Крутяков Е.Н. и др. Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей. Патент на изобретение № 2497533.
  11. Струков В.И., Джоунс О.В., Крутяков Е.Н., и др. Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей. Патент на изобретение № 2498811. Приоритет изобретения от 19.04.2012.
  12. Струков В.И., Джоунс О.В., Крутяков Е.Н. и др. Способ диагностики остеопороза методом определения динамики закрытия полостных образований для оценки эффективности применения различных остеопротекторов. Патент на изобретение № 2511430. Приоритет с 19.04.2012.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies